Intranasal Human Recombinant Modified Glucagon-Like Peptide-1: High Antihyperglycemic Activity and Duration of Action in Mice

Rykalina, NV; Askerova, EV; Bulushova, NV; Kozlov, DG

Kozlov, DG (corresponding author), Natl Res Ctr, GosNIIgenetika, State Res Inst Genet & Select Ind Microorganisms, Kurchatov Inst, Moscow, Russia.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2020; 169 (1): 53

Abstract

The study compared effectiveness of intranasal administration of glypin (human recombinant modified glucagon-like peptide-1) and reference drug Victoz......

Full Text Link